United States · FDA National Drug Code directory

Thyro-Pro T019

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71742-0013_7cc99dd9-f722-44e6-a224-a3a40d47af5a
Product NDC
71742-0013
Form
LIQUID
Composition / generic term
Fucus Vesiculosus, Spongia Tosta, Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Bromium, Calcarea Carbonica, Iodium, Lachesis Mutus, Pulsatilla (Vulgaris)
Labeler
Guangzhou Renuma Medical Systems Co., Ltd
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20171026
Source listing expiry
20261231

Source-listed ingredients

  • FUCUS VESICULOSUS — 3 [hp_X]/mL
  • SPONGIA OFFICINALIS SKELETON, ROASTED — 3 [hp_X]/mL
  • SUS SCROFA ADRENAL GLAND — 6 [hp_X]/mL
  • SUS SCROFA PITUITARY GLAND — 6 [hp_X]/mL
  • SUS SCROFA THYROID — 6 [hp_X]/mL
  • BROMINE — 12 [hp_X]/mL
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE — 12 [hp_X]/mL
  • IODINE — 12 [hp_X]/mL
  • LACHESIS MUTA VENOM — 12 [hp_X]/mL
  • PULSATILLA VULGARIS — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 59 mL in 1 BOTTLE, DROPPER (71742-0013-1) · 71742-0013-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →